Form 4: Vaxart Director Robert Yedid Acquires Shares and Stock Options

Director Robert A. Yedid reports acquisition of Vaxart shares and stock options.

Summary

• On June 11, 2024, Robert A. Yedid, a director of Vaxart, Inc., acquired 16,000 shares of common stock at $0 and 95,400 stock options with an exercise price of $0.77.
• Following the transaction, Yedid directly owns 34,490 shares of Vaxart common stock and 95,400 stock options.
• The shares were granted upon the vesting of restricted stock units, which will vest on the earlier of the date immediately prior to the 2025 annual meeting of stockholders or June 11, 2025.

Sentiment

Score: 6

Explanation: Neutral sentiment as it's a standard insider transaction disclosure. The acquisition of shares and options could be interpreted as a positive signal, but it's not definitive.

Positives

• The acquisition of shares and stock options by a director could be seen as a positive sign, indicating confidence in the company's future prospects.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment if viewed as a sign of confidence by a company director.

Key Dates